Physician profile

Tal Morr

Prosthodontics · Miami, FL

NPI 1215248513

$1,576.14

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$442.64
Gift$257.04

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ivoclar Vivadent, INC. $603.25 2022-2024
Ultradent Products INC $325.52 2021-2024 Opalescence
A-Dec, INC. $250.00 2022
3m Company $200.00 2021
Southern Implants North America INC $73.55 2021
Dentsply Sirona INC $68.90 2019-2024 Astra Tech Implant System
Straumann USA LLC $22.99 2022
Dentsply Ih INC. $16.47 2019
Allergan, INC. $15.46 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tal Morr

$1,576.14

in general payments reported 2019-2025

Years
2019-2024
Top company
Ivoclar Vivadent, INC.

https://glasscript.com/doctor/99920/tal-morr

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.